EUCanScreen Pilot Study on Gastric Cancer Risk Reduction Presented

at TOGAS Conference

On 11 September, the EUCanScreen pilot study on gastric cancer risk reduction during colorectal cancer screening was presented at the European Union’s project “Towards Gastric Cancer Screening” (TOGAS) Conference, held at the Università Cattolica del Sacro Cuore in Rome.

The External Advisory Board involves prominent researchers from all over the World, including – Yi-Chia Lee, a world-renowned pioneer in similar screening studies and leading gastric cancer prevention physician at National Taiwan University Hospital.

Prof. Lee has spent over 20 years leading a successful gastric cancer prevention programme on Matsu Island, once known for the highest stomach cancer rates in Taiwan. Building on this success, the approach has been gradually expanded and is now set to become a nationwide policy in Taiwan.

During the conference, Prof. Lee gave an in-depth analysis of the proposed EU protocol, comparing it with the research he is leading in Taiwan. His insights helped position the EUCanScreen initiative within the broader international context of evidence-based cancer prevention strategies.

More information: CNA article

#EuCanScreen #CancerScreening #HealthCare #CancerPrevention #GastricCancer

🔗 Please don’t forget to Subscribe to EuCanScreen Newsletter! 💪

Subscribe to our newsletter to get news and updates.

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959